PatientsLikeMe ™
Already a member? Log in
with patients just like you.
- Select a community
- MS
-
Find out more about the PatientsLikeMe
MS Community
Natalizumab Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Tysabri
What is Natalizumab? Natalizumab is a monoclonal antibody given by infusion and used in the treatment of MS and Crohn's disease. It has been shown to slow progression and reduce relapses in MS. It is currently sold under the brand name Tysabri.
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
490 patients in the community are taking or have taken Natalizumab.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 393 | 80% |
| Other | 26 | 5% |
| General health | 10 | 2% |
| Stiffness/spasticity | 6 | 1% |
| Fatigue | 3 | <1% |
| Don't know | 2 | <1% |
| disease-related symptoms | 2 | <1% |
| no energy | 1 | <1% |
| Pain | 1 | <1% |
| Weakness in legs | 1 | <1% |
| Sensation | 1 | <1% |
| Mobility | 1 | <1% |
| transfering | 1 | <1% |
| 0 g Monthly | 0 mg Monthly | 0 other Monthly | 0 Monthly | 300 mg As needed | 300 mg Monthly | 1 g Monthly | 1 mg Monthly | 1 Monthly | 4 mg Monthly | 5 mg Monthly | 15 mg Monthly | 20 mg Monthly | 25 mg Monthly | 30 mg Monthly | 50 mg Monthly | 100 mg Monthly | 200 mg Monthly | 300 mg Monthly | 1000 mg Monthly | 300 mg Daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1
|
161
|
1
|
25
|
2
|
1
|
1
|
1
|
5
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
3
|
4
|
195
|
1
|
10
|
||
Duration
How long current patients have been taking Natalizumab or how long patients were taking Natalizumab before stopping.
Currently taking Natalizumab
Stopped taking Natalizumab
Patient Reported Evaluations
Results from 52 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Major | 21% | 10 |
|---|---|---|
| Moderate | 29% | 14 |
| Slight | 15% | 7 |
| None | 13% | 6 |
| Can't tell | 23% | 11 |
Slow my MS progress
Side-effects (as an overall problem)
| Severe | 6% | 3 |
|---|---|---|
| Moderate | 2% | 1 |
| Mild | 42% | 22 |
| None | 50% | 26 |
Top reported side-effects include: tiredness, mild headache, Headaches
Summary results are based on 52 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (2 of 52)
-
- LadyMac
- Sex: F
- Sensation: Moderate
- Overall: Mild
- Cognition: none
- Vision: moderate
- Speech: none
- Swallowing: mild
- Upper limb: moderate
- Walking: moderate
- See profile
-
by LadyMac
Aug 18, 2008
- EfficacyCan't tell
- Side-effectsNone
- Slow my MS progress
- Advice/Tips
- Just be positive about the drug, that it's for you and what you need and want. Positive thinking can help more then one thinks. I'm looking forward to my next infusion next month. August '08 was my first infusion and I was happy with the TOUCH program. Was a very relaxing experience.
- See full evaluation
-
1 helpful mark
-
- cureseeker
- Sex: F
- Sensation: Moderate
- Overall: Mild
- Cognition: moderate
- Vision: moderate
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: moderate
- See profile
-
by cureseeker
Aug 18, 2008
- EfficacySlight
- Side-effectsMild
- Slow my MS progress
- See full evaluation
-
0 helpful marks